Who owns IMMUNEERING CORP - CLASS A?
- Ticker: IMRX
- CUSIP Number: 45254e107
Tip: Access positions for across all investors
Analyze quarterly positions in Immuneering Corp - Class A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Immuneering Corp - Class A stock
Who bought or sold IMMUNEERING CORP - CLASS A this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Cormorant Asset Management | 3.3M | $9.5M | -22% | Mar 2024 |
|
Citadel Advisors | 1.9M | $5.4M | -9% | Mar 2024 |
|
BlackRock | 1.4M | $4.0M | -45% | Mar 2024 |
|
Vanguard Group | 1.2M | $3.5M | 12% | Mar 2024 |
|
T. Rowe Price Associates | 910k | $2.6M | -73% | Mar 2024 |
|
Geode Capital Management | 463k | $1.3M | 7% | Mar 2024 |
|
Goldman Sachs Group | 454k | $1.3M | -1% | Mar 2024 |
|
HighVista Strategies | 255k | $736k | 0% | Mar 2024 |
|
FMR | 233k | $674k | -62% | Mar 2024 |
|
Northern Trust | 176k | $509k | -5% | Mar 2024 |
|
TD Asset Management | 151k | $436k | -24% | Mar 2024 |
|
Bridgeway Capital Management | 114k | $330k | 192% | Mar 2024 |
|
Exchange Traded Concepts | 98k | $284k | 464% | Mar 2024 |
|
Millennium Management | 63k | $183k | 453% | Mar 2024 |
|
Charles Schwab Investment Management | 61k | $175k | 0% | Mar 2024 |
|
Bank of New York Mellon | 54k | $155k | -16% | Mar 2024 |
|
Adage Capital Partners GP | 50k | $145k | -74% | Mar 2024 |
|
Morgan Stanley | 46k | $132k | 114% | Mar 2024 |
|
Nuveen Asset Management | 44k | $127k | 9% | Mar 2024 |
|
CI Private Wealth | 43k | $125k | 48% | Mar 2024 |
|
First Manhattan | 33k | $96k | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 31k | $91k | 88% | Mar 2024 |
|
UBS Group | 29k | $84k | 100% | Mar 2024 |
|
Corton Capital | 27k | $77k | -2% | Mar 2024 |
|
Barclays | 26k | $75k | -26% | Mar 2024 |
|
XTX Topco | 25k | $72k | 100% | Mar 2024 |
|
Rhumbline Advisers | 21k | $61k | 5% | Mar 2024 |
|
Pnc Financial Services | 20k | $58k | 0% | Mar 2024 |
|
Janney Montgomery Scott | 16k | $46k | -20% | Mar 2024 |
|
Jane Street | 13k | $39k | 100% | Mar 2024 |
|
Bank of America Corporation | 13k | $38k | -47% | Mar 2024 |
|
American Century Companies | 12k | $33k | 1% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 11k | $33k | -4% | Mar 2024 |
|
MetLife Investment Advisors | 11k | $83k | 0% | Dec 2023 |
|
Oracle Alpha | 11k | $32k | -5% | Mar 2024 |
|
American International | 11k | $82k | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 9.7k | $28k | 6% | Mar 2024 |
|
Jpmorgan Chase & Co | 9.3k | $27k | -42% | Mar 2024 |
|
Wells Fargo & Company | 7.0k | $20k | 15% | Mar 2024 |
|
Citigroup | 5.5k | $16k | 46% | Mar 2024 |
|
Tower Research Capital | 4.9k | $14k | 51% | Mar 2024 |
|
California State Teachers Retirement System | 2.5k | $7.3k | -49% | Mar 2024 |
|
Legal & General Group | 2.2k | $6.3k | 0% | Mar 2024 |
|
Summit Investment Advisors | 1.7k | $4.8k | 0% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.2k | $8.6k | 0% | Dec 2023 |
|
Advisor Group Holdings | 1.0k | $2.9k | 100% | Mar 2024 |
|
Royal Bank of Canada | 784.00 | $2.8k | -89% | Mar 2024 |
|
Amalgamated Bank | 684.00 | $2.0k | -74% | Mar 2024 |
|
Harbour Investments | 25.00 | $184.000000 | 0% | Dec 2023 |
|
Nelson, Van Denburg & Campbell Wealth Management | 4.00 | $11.000000 | 100% | Mar 2024 |
|
CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Immuneering Corp - Class A?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
ExodusPoint Capital Management | Sep 2023 | 121k | $928k |
HighTower Advisors | Dec 2023 | 24k | $176k |
Virtu Financial | Dec 2023 | 11k | $84k |
Mirae Asset Global Investments | Dec 2023 | 11k | $82k |
Federated Investors | Sep 2023 | 75.00 | $576.000000 |